| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1032204887 |
| P356 | DOI | 10.1038/NATURE17994 |
| P3181 | OpenCitations bibliographic resource ID | 2707623 |
| P698 | PubMed publication ID | 27093288 |
| P50 | author | Victor A Kostyuchenko | Q30347537 |
| Guntur Fibriansah | Q54435388 | ||
| Justin S G Ooi | Q85520179 | ||
| Shee-Mei Lok | Q89723065 | ||
| Thiam Seng Ng | Q90179102 | ||
| P2093 | author name string | Jian Shi | |
| Shuijun Zhang | |||
| Elisa X Y Lim | |||
| P2860 | cites work | Biology of Zika Virus Infection in Human Skin Cells | Q22330706 |
| Detection of Zika virus in urine | Q22330729 | ||
| Complete Coding Sequence of Zika Virus from a French Polynesia Outbreak in 2013 | Q22330741 | ||
| Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study | Q23012849 | ||
| The 3.8 Å resolution cryo-EM structure of Zika virus | Q23680595 | ||
| Association between Zika virus and microcephaly in French Polynesia, 2013–15: a retrospective study | Q24255260 | ||
| Possible Association Between Zika Virus Infection and Microcephaly — Brazil, 2015 | Q24261167 | ||
| US health officials investigate sexually transmitted Zika virus infections | Q24261241 | ||
| Isolation of infectious Zika virus from saliva and prolonged viral RNA shedding in a traveller returning from the Dominican Republic to Italy, January 2016 | Q24310987 | ||
| The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry | Q24620686 | ||
| Structure of dengue virus: implications for flavivirus organization, maturation, and fusion | Q24736810 | ||
| Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination | Q26778405 | ||
| Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains | Q27469847 | ||
| Crystal Structure of the West Nile Virus Envelope Glycoprotein | Q27477648 | ||
| Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation | Q27643140 | ||
| Cryo-EM structure of the mature dengue virus at 3.5-Å resolution | Q27675507 | ||
| Crystal Structure of the Japanese Encephalitis Virus Envelope Protein | Q27676100 | ||
| Dengue structure differs at the temperatures of its human and mosquito hosts | Q27677270 | ||
| Structural Changes in Dengue Virus When Exposed to a Temperature of 37 C | Q27677962 | ||
| Immature and Mature Dengue Serotype 1 Virus Structures Provide Insight into the Maturation Process | Q27677965 | ||
| Electron counting and beam-induced motion correction enable near-atomic-resolution single-particle cryo-EM. | Q27677990 | ||
| Near-Atomic Resolution Cryo-Electron Microscopic Structure of Dengue Serotype 4 Virus | Q27680452 | ||
| The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution | Q27730234 | ||
| Features and development of Coot | Q27861079 | ||
| Structure of West Nile Virus | Q29618173 | ||
| Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen? | Q30051605 | ||
| DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers | Q36352752 | ||
| Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. | Q40486490 | ||
| Averaging tens to hundreds of icosahedral particle images to resolve protein secondary structure elements using a Multi-Path Simulated Annealing optimization algorithm | Q42610211 | ||
| P433 | issue | 7603 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| Zika virus | Q202864 | ||
| virus structure | Q55568924 | ||
| P1104 | number of pages | 4 | |
| P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
| P304 | page(s) | 425-428 | |
| P577 | publication date | 2016-04-19 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Structure of the thermally stable Zika virus | |
| P478 | volume | 533 |
| Q59132624 | A Comprehensive Review of the Manifestations and Pathogenesis of Zika Virus in Neonates and Adults |
| Q41596362 | A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential |
| Q52603628 | A New In Vivo Model to Study Protective Immunity to Zika Virus Infection in Mice With Intact Type I Interferon Signaling. |
| Q28954816 | A Reverse Genetics Platform That Spans the Zika Virus Family Tree |
| Q56000955 | A VSV-based Zika virus vaccine protects mice from lethal challenge |
| Q59349966 | A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice |
| Q56341869 | A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein |
| Q28729772 | A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine |
| Q97545865 | A complex between the Zika virion and the Fab of a broadly cross-reactive neutralizing monoclonal antibody revealed by cryo-EM and single particle analysis at 4.1 Å resolution |
| Q28950443 | A human antibody against Zika virus crosslinks the E protein to prevent infection |
| Q84957921 | A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein |
| Q96339730 | A quantitative luciferase-based cell-cell fusion assay to measure four-serotype dengue virus E protein-triggered membrane fusion |
| Q55512220 | A sensitive electrochemical immunosensor for label-free detection of Zika-virus protein. |
| Q28804076 | A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis |
| Q47549520 | A single residue in the αB helix of the E protein is critical for Zika virus thermostability |
| Q39017347 | AChiralPentagonalPolyhedralFramework forCharacterizingVirusCapsidStructures |
| Q55084443 | Advances in the research and development of therapeutic antibodies against the Zika virus. |
| Q44843596 | An Alphavirus E2 Membrane-Proximal Domain Promotes Envelope Protein Lateral Interactions and Virus Budding |
| Q60031636 | An Evolutionary Insight into Zika Virus Strains Isolated in the Latin American Region |
| Q38157065 | An Integrative Analysis Reveals a Central Role of P53 Activation via MDM2 in Zika Virus Infection Induced Cell Death |
| Q28119677 | Analysis of Synonymous Codon Usage Bias of Zika Virus and Its Adaption to the Hosts |
| Q28827957 | Antibody responses to Zika virus infections in flavivirus-endemic environments |
| Q38645467 | Atomic cryo-EM structures of viruses |
| Q27010857 | Available Evidence of Association between Zika Virus and Microcephaly |
| Q96024265 | Baculovirus Surface Display of Zika Virus Envelope Protein Protects against Virus Challenge in Mouse Model |
| Q55277816 | Biochemistry and Molecular Biology of Flaviviruses. |
| Q26252060 | Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype |
| Q83225458 | Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics |
| Q41918216 | CD-loop extension in Zika virus envelope protein key for stability and pathogenesis |
| Q95941847 | Capsid protein is central to the birth of flavivirus particles |
| Q89723069 | Capsid protein structure in Zika virus reveals the flavivirus assembly process |
| Q27468613 | Characterization of a Zika Virus Isolate from Colombia |
| Q28114506 | Characterization of cytopathic factors through genome-wide analysis of the Zika viral proteins in fission yeast |
| Q98205356 | Chemical proteomics tracks virus entry and uncovers NCAM1 as Zika virus receptor |
| Q28353933 | Comparative Normal Mode Analysis of the Dynamics of DENV and ZIKV Capsids |
| Q96292850 | Computational modelling of flavivirus dynamics: the ins and outs |
| Q37642687 | Conformational changes in intact dengue virus reveal serotype-specific expansion |
| Q64979406 | Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model. |
| Q30250932 | Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope |
| Q40047603 | Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections |
| Q37419887 | Culex pipiens quinquefasciatus: a potential vector to transmit Zika virus |
| Q27868594 | Cytoarchitecture of Zika virus infection in human neuroblastoma and Aedes albopictus cell lines |
| Q38157397 | DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection. |
| Q27654848 | Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity |
| Q33798068 | Delineating antibody recognition against Zika virus during natural infection |
| Q90829180 | Dengue NS2A Protein Orchestrates Virus Assembly |
| Q26247258 | Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus |
| Q61795493 | Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy |
| Q28577861 | Dengue and Zika viruses: lessons learned from the similarities between these Aedes mosquito-vectored arboviruses |
| Q62485179 | Determinants of Zika virus host tropism uncovered by deep mutational scanning |
| Q64247461 | Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein Structure |
| Q47269331 | Development of envelope protein antigens to serologically differentiate Zika from dengue virus infection |
| Q62485317 | Diagnosing Zika virus infection against a background of other flaviviruses: Studies in high resolution serological analysis |
| Q58784010 | Early Events in Japanese Encephalitis Virus Infection: Viral Entry |
| Q55267707 | Electron cryomicroscopy as a powerful tool in biomedical research. |
| Q37578543 | Emergence of Epidemic Zika Virus Transmission and Congenital Zika Syndrome: Are Recently Evolved Traits to Blame? |
| Q51340434 | Emerging Infectious Diseases. |
| Q98578994 | Enhanced effect of modified Zika virus E antigen on the immunogenicity of DNA vaccine |
| Q97535084 | Envelope protein ubiquitination drives entry and pathogenesis of Zika virus |
| Q56000988 | Evolution of Two Major Zika Virus Lineages: Implications for Pathology, Immune Response, and Vaccine Development |
| Q45324728 | Evolution of neurovirulent Zika virus |
| Q101116526 | Evolution of resistance to fluoroquinolones by dengue virus serotype 4 provides insight into mechanism of action and consequences for viral fitness |
| Q26252232 | Extended surface for membrane association in Zika virus NS1 structure |
| Q90244931 | Flavivirus envelope protein glycosylation: impacts on viral infection and pathogenesis |
| Q38158126 | Flavivirus structural heterogeneity: implications for cell entry |
| Q57805476 | Flaviviruses have imperfect icosahedral symmetry |
| Q56341104 | Functional Genomics and Immunologic Tools: The Impact of Viral and Host Genetic Variations on the Outcome of Zika Virus Infection |
| Q47233096 | Geometric Defects and Icosahedral Viruses |
| Q96609514 | High flavivirus structural plasticity demonstrated by a non-spherical morphological variant |
| Q59352413 | High-Throughput Fitness Profiling of Zika Virus E Protein Reveals Different Roles for Glycosylation during Infection of Mammalian and Mosquito Cells |
| Q47547869 | Higher Cytopathic Effects of a Zika Virus Brazilian Isolate from Bahia Compared to a Canadian-Imported Thai Strain |
| Q38156921 | Highly Sensitive, Engineered Magnetic Nanosensors to Investigate the Ambiguous Activity of Zika Virus and Binding Receptors |
| Q56337984 | Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus |
| Q30235062 | Host-Virus Interaction of ZIKA Virus in Modulating Disease Pathogenesis |
| Q27468554 | How Did Zika Virus Emerge in the Pacific Islands and Latin America? |
| Q63248442 | Human antibody response to Zika targets type-specific quaternary structure epitopes |
| Q28833079 | Hydrocephalus and arthrogryposis in an immunocompetent mouse model of ZIKA teratogeny: A developmental study |
| Q100427968 | Identification of a pocket factor that is critical to Zika virus assembly |
| Q61795459 | Identification of small molecule inhibitors targeting the Zika virus envelope protein |
| Q28119651 | Identifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus Species |
| Q27313484 | Illustrating and homology modeling the proteins of the Zika virus |
| Q48514697 | Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells. |
| Q40037937 | Immunization with truncated envelope protein of Zika virus induces protective immune response in mice |
| Q62485447 | Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika |
| Q54241842 | Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases. |
| Q24289645 | Inhibitory antibodies targeting emerging viruses: advancements and mechanisms |
| Q38289203 | Interaction of Zika Virus Envelope Protein with Glycosaminoglycans |
| Q29051494 | Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection |
| Q66679510 | Large-scale analysis of B-cell epitopes of envelope: Implications for Zika vaccine and immunotherapeutic development |
| Q52562578 | Lethal Zika Virus Disease Models in Young and Older Interferon α/β Receptor Knock Out Mice. |
| Q54241921 | Longitudinal Analysis of Antibody Cross-Neutralization Following Zika and Dengue Virus Infection in Asia and the Americas. |
| Q41930666 | Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses |
| Q62485400 | Maternal immunity and antibodies to dengue virus promote infection and Zika virus-induced microcephaly in fetuses |
| Q25019713 | Mechanisms of Zika Virus Infection and Neuropathogenesis |
| Q52431569 | Microbiology catches the cryo-EM bug. |
| Q95322772 | Molecular Basis of Differential Stability and Temperature Sensitivity of ZIKA versus Dengue Virus Protein Shells |
| Q90179106 | Molecular basis of dengue virus serotype 2 morphological switch from 29°C to 37°C |
| Q38157646 | Molecular cloning and characterization of the genes encoding the proteins of Zika virus |
| Q26746069 | Molecular signatures associated with ZIKV exposure in human cortical neural progenitors |
| Q38157121 | Monoclonal antibodies against Zika virus: Therapeutics and their implications for vaccine design |
| Q49791115 | N-glycosylation of Viral E Protein Is the Determinant for Vector Midgut Invasion by Flaviviruses |
| Q97539391 | Nanosensors based on LSPR are able to serologically differentiate dengue from Zika infections |
| Q33687913 | Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability |
| Q54217649 | Nervous System Injury and Neuroimaging of Zika Virus Infection. |
| Q27927995 | Neurological manifestations of Zika virus infection |
| Q27924235 | Neutralization mechanism of a highly potent antibody against Zika virus |
| Q41919737 | Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III. |
| Q60487631 | Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region |
| Q56354615 | PARP12 suppresses Zika virus infection through PARP-dependent degradation of NS1 and NS3 viral proteins |
| Q88788400 | Partial Intrinsic Disorder Governs the Dengue Capsid Protein Conformational Ensemble |
| Q47263584 | Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge |
| Q54231305 | Physiological temperatures reduce dimerization of dengue and Zika virus recombinant envelope proteins. |
| Q38157816 | Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice |
| Q29364523 | Potential mechanisms of Zika-linked microcephaly |
| Q61053973 | Pre-Existing Dengue Immunity Drives a DENV-Biased Plasmablast Response in ZIKV-Infected Patient |
| Q33715238 | Preventive and therapeutic challenges in combating Zika virus infection: are we getting any closer? |
| Q54221789 | Probing Molecular Insights into Zika Virus⁻Host Interactions. |
| Q56348817 | Probing Zika virus neutralization determinants with glycoprotein mutants bearing linear epitope insertions |
| Q28119679 | Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection |
| Q99731978 | Protective and enhancing interactions among dengue viruses 1-4 and Zika virus |
| Q38771712 | Protein Interactions during the Flavivirus and Hepacivirus Life Cycle |
| Q28223065 | Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors |
| Q92689707 | Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy |
| Q54215484 | Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope. |
| Q55387941 | Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors. |
| Q38158407 | Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure |
| Q51782806 | Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice. |
| Q91928841 | Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice |
| Q30145646 | Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico |
| Q55567656 | Refinement and Analysis of the Mature Zika Virus Cryo-EM Structure at 3.1 Å Resolution. |
| Q26252115 | Research and development of Zika virus vaccines |
| Q56341947 | Role of Zika Virus prM Protein in Viral Pathogenicity and Use in Vaccine Development |
| Q40131151 | Roles of Pro-viral Host Factors in Mosquito-Borne Flavivirus Infections |
| Q90205634 | Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease |
| Q62485314 | Shortening of Zika virus CD-loop reduces neurovirulence while preserving antigenicity |
| Q47558373 | Small Molecules and Antibodies for Zika Therapy |
| Q27928065 | South-east Asian Zika virus strain linked to cluster of cases in Singapore, August 2016 |
| Q40056291 | Structural Basis of Zika Virus-Specific Antibody Protection |
| Q55084358 | Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection. |
| Q61053963 | Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope |
| Q24740325 | Structural basis of potent Zika–dengue virus antibody cross-neutralization |
| Q47555436 | Structural biology of Zika virus and other flaviviruses |
| Q40037585 | Structural investigation of C6/36 and Vero cell cultures infected with a Brazilian Zika virus |
| Q28223583 | Structure of the immature Zika virus at 9 Å resolution |
| Q59359675 | Structure, function and antagonism of semen amyloids |
| Q46261471 | Structures and Functions of the Envelope Glycoprotein in Flavivirus Infections. |
| Q90113577 | Structures of enveloped virions determined by cryogenic electron microscopy and tomography |
| Q24067948 | Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody |
| Q28804225 | The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis |
| Q47229433 | The Zika virus envelope protein glycan loop regulates virion antigenicity |
| Q47558217 | The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design. |
| Q94522058 | The continued threat of emerging flaviviruses |
| Q59069221 | The emergence of Zika virus and its new clinical syndromes |
| Q51336389 | The immunology of Zika Virus. |
| Q41918254 | Therapeutic Approaches for Zika Virus Infection of the Nervous System |
| Q58664017 | Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide |
| Q61795505 | Transfusion-Transmitted Zika Virus Infection in Pregnant Mice Leads to Broad Tissue Tropism With Severe Placental Damage and Fetal Demise |
| Q25161350 | Ultrastructure of Zika virus particles in cell cultures |
| Q28735954 | Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis |
| Q93060459 | Virology Downunder, a meeting commentary from the 2019 Lorne Infection and Immunity Conference, Australia |
| Q64988889 | West Nile virus infection and interferon alpha treatment alter the spectrum and the levels of coding and noncoding host RNAs secreted in extracellular vesicles. |
| Q38157725 | Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Challenges of a Dengue Vaccine |
| Q26700454 | Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome |
| Q29365254 | Zika Virus Induced Cellular Remodeling |
| Q26247150 | Zika Virus Infection and Development of a Murine Model |
| Q26970782 | Zika Virus Is Not Uniquely Stable at Physiological Temperatures Compared to Other Flaviviruses |
| Q28733400 | Zika Virus Pathogenesis and Tissue Tropism |
| Q27928066 | Zika Virus Strains Potentially Display Different Infectious Profiles in Human Neural Cells |
| Q47558310 | Zika Virus Structure, Maturation, and Receptors |
| Q92313109 | Zika Virus Targeting by Screening Inhibitors against NS2B/NS3 Protease |
| Q66679244 | Zika Virus Transmission Through Blood Tissue Barriers |
| Q91868394 | Zika Virus as Oncolytic Therapy for Brain Cancer: Myth or Reality? |
| Q38158918 | Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence and Neuro-Immune Interactions |
| Q63246295 | Zika Virus-Specific IgY Results Are Therapeutic Following a Lethal Zika Virus Challenge without Inducing Antibody-Dependent Enhancement |
| Q38969772 | Zika Virus: Immunity and Vaccine Development |
| Q30235853 | Zika Virus: Transmission, Detection, Control, and Prevention |
| Q40037723 | Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic? |
| Q47168453 | Zika vaccine candidates progress through nonclinical development and enter clinical trials |
| Q28027604 | Zika virus is not thermostable: very effective virus inactivation during heat treatment (pasteurization) of human serum albumin |
| Q54225573 | Zika virus propagation and release in human fetal astrocytes can be suppressed by neutral sphingomyelinase-2 inhibitor GW4869. |
| Q90115502 | Zika virus proteins at an atomic scale: how does structural biology help us to understand and develop vaccines and drugs against Zika virus infection? |
| Q56354521 | Zika virus vaccines |
| Q30145640 | Zika virus-like particle (VLP) based vaccine |
| Q30235530 | Zika virus: An emerging flavivirus |
| Q24244835 | Zika virus: An update on epidemiology, pathology, molecular biology, and animal model |
| Q63739867 | Zika virus: mapping and reprogramming the entry |
| Q27468686 | ZikaVR: An Integrated Zika Virus Resource for Genomics, Proteomics, Phylogenetic and Therapeutic Analysis |
Search more.